Fig. 2.
TCR-β gene rearrangements shown by Southern blot analysis in Patient 5's peripheral blood cells before and after CSA therapy. The abnormal band is indicated by an arrow. Molt-4 and DHL-4 cells are shown as positive and negative controls, respectively.